Welcome to the July/August edition of Global Vascular Digest. The focus of this edition is Aortic Disease: New Technologies and Advanced Treatment. My sincere appreciation goes to Drs. Richard Kovach and Steve Henao for their editorial contributions to this edition as well as to our guest editor, Dr. Grayson Wheatley, III I am confident you will find valuable and relevant information on this subject matter.
I would like to thank all of my fellow HIPG members and colleagues who attended NCVH 2016. Once again, this conference exceeded expectations in showcasing some of the most gifted physicians delivering the latest information about the newest modalities and research that are being used to advance the treatment of peripheral vascular disease and critical limb ischemia.
We also conducted a very successful HIPG member meeting on May 31 during NCVH. Agenda items included updates on critical clinical trials and discussion of the HIPG executive committee nomination process. Congratulations to our new officers.
Lastly, I encourage all readers who are not acheterdufrance.com currently HIPG members to consider membership and help us shape the future of vascular medicine and intervention.